This website uses cookies to ensure you get the best experience on our website. By continuing to browse this website, you agree to this use. Learn more
alabus ag | Birchstr. 189 | 8050 Zürich | +41 44 315 18 90 |  contact
Oct 7, 2014


Leading university hospitals Zürich and Lausanne, and Actelion Pharmaceuticals as sponsor, launch a study (LONGACT), which correlates activity data of participants with medical observations. The participants of the study receive Fitbit bands as trackers. The activity data from these bands are securely consolidated in an alabus registry and made available to the medical specialists for analysis. This is the first big data project on the alabus platform.